Filament Health Files 20th Patent Application Including Three International PCT Applications Post published:September 1, 2021 Post category:Press Release
Filament Health Successfully Completes Industry-first Export of Natural GMP Psychedelics to the United States Post published:August 26, 2021 Post category:Press Release
Filament Health Announces Q2 2021 Financial Results Post published:August 16, 2021 Post category:Press Release
Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin Post published:August 3, 2021 Post category:Press Release
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing Post published:July 29, 2021 Post category:Press Release
Filament Health to Host Virtual Investor Event Post published:July 20, 2021 Post category:Press Release
Exclusively-Natural Psychedelic Pharma Company, Filament Health, Lists on the NEO Exchange Post published:June 24, 2021 Post category:Press Release
Interview: Dr. Josh Woolley (TrPR) and Ben Lightburn (Filament Health) Post published:June 22, 2021 Post category:Interview
Filament Health Corp. Announces Approval for Listing on the Neo Exchange Post published:June 22, 2021 Post category:Press Release
Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement Financing Post published:June 21, 2021 Post category:Press Release